Site Map
- Home
- Events
- Suppliers
- Knowledge Share
- Knowledge Share
- Understanding the Psyche of Japanese Pharmaceutical Consumers
- Improving Performance - Pharmaceutical Manufacturing
- Health Care Reform will not fly!
- Dangerous prescription drugs might really be.
- pharmaceuticals are Weapons of Mass Prescription
- Coming attractions in life sciences
- Pain-free PCR: BJS Biotechnologies creates UF1
- Alexion Receives CHMP Positive Opinion for Soliris(R) (eculizumab) in Patients with Atypical Hemolyt
- Roger Tung, CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE
- Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuti
- Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
- ThromboGenics Begins Phase III Program With Microplasmin
- Pfizer to Acquire Wyeth, Creating the World s Premier Biopharmaceutical Company
- USA to Establish Helsinn Therapeutics (US) Inc. - Announced by Helsinn
- Enzon Announces IND Acceptance for Its Survivin Antagonist
- FDA approval for extended-release tramadol capsules
- Intas Biopharma to market PEMETREXED in India
- Treat Moderate to Severe Acne Scars
- Heat-Stable Version of HIV Protease Inhibitor
- Hospitalizations and Emergency Room Visits
- Nimotuzumab In Non-Small-Cell Lung Cancer
- Non-safety-related voluntary market patches announced
- Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Resea
- Immunotech Completes Merger Acquisition
- KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for GERD Treatment
- New Sani-Tech(R) Ultra delivers improved performance
- New Peptide shown even more effective compared to hydroquinone
- Durham biotech Chimerix raises $16.1 million
- BET Surface Area – A Useful Tool for Determining the Source of Batch-to-Batch Variation in Processab
- Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
- Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Gl
- FDA approves pralatrexate for peripheral T-cell lymphoma
- Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experi
- Biodel seeks US FDA approval for mealtime insulin VIAject to treat diabetes
- Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
- Luna Innovations to Provide Corporate Update on January 11, 2010
- Financing Outlook for the US Biotechnology Industry
- MicroBioLogics Releases New Product For Growth Promotion Testing Of Microbiological Culture Media In
- Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
- Caleco Pharma Corp. (CAEH.OB) Leads The Best Stock Picks List
- NPA group wins PPMA elections
- BPA: It's in Your Urine. But Is It Safe?
- Four Leading Pharmaceutical Companies Select Cegedim Dendrite’s Customer Master Data Management Solu
- Mindlance Life Sciences Acquires Pharmaceutical Clinical Associates
- T-Ray Science, Inc. Announces Changes in Management
- Vertex Reviews 2010 Business Priorities to Support Goal of Becoming Fully-Capable Biopharmaceutical
- Novo Nordisk A/S: Regulatory Approval
- FDA has approved the marketing of Ampyra™
- Teva Announces Tentative Approval of Generic Femara® Tablets
- Product Placement Initiated Means Roll Out Beginning
- Ceplene® Included in Swedish AML Medical Guidelines Announced by EpiCept
- Vertex Pharmaceuticals Announces Redemption Date for 4.75% Convertible Senior Subordinated Notes due
- Approval in Japan of New Formulation of Mitsubishi Tanabe Pharma's Edaravone Will Further Bolster it
- Clarient to Release 2009 Fourth Quarter and Year-End Financial Results on Wednesday, March 10th
- U.S. Food and Drug Administration Approves Cayston(R) for the Improvement of Respiratory Sym
- Simcere Pharmaceutical Group Announces Addition to Senior Management Team
- Global Anti Counterfeit Packaging Technologies Market for Food and Pharmaceuticals
- Vicor Technologies, Inc. (OTCBB: VCRT) A New Vital Sign
- European Medicines Agency Grants to ADIENNE Pharma and Biotech the exclusive Marketing Authorization
- King Pharmaceuticals Announces US Department of Justice Settlement
- dinlivskraft.se Announces The Launch Of Its New D-Vitamin Supplements
- Impax Laboratories Schedules Conference Call for First Quarter 2010 Financial Results Read more: ht
- Pharmaceutical Companies How to Comply with New FDA Expectations for Quality Systems
- Inspire shares rise on dry-eye product approval
- CPEX Pharmaceuticals Appoints Robert Forrester To Board Of Directors
- FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
- Lorus Therapeutics Announces Share Consolidation
- Mission Pharmacal Launches New Prescription Prenatal Vitamin, CitraNatal® Harmony
- Valeant Acquires Aton Pharma
- Johnson & Johnson Pharmaceutical Research & Development Reports Phase 2b Clinical Trial Results
- BASF Fine Chemicals Switzerland SA and BASF Orgamol Pharma Solutions SA merger announced
- Par Pharmaceutical Begins Shipment of Generic Zegerid®
- Novo launches insulin dosing app
- FDA Panel Rejects Arena's Weight-Loss Drug
- Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl
- AmerisourceBergen Authorizes a New $500 Million Share Repurchase Program
- BJS Biotechnologies launches UF1 at Biotechnica
- Cadila Pharmaceuticals secures Wellcome Trust Award
- Cyplasin Biomedical Ltd Announces Corporate 2010 Update
- BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
- Dr Soon-Shiong acquires GlowCaps-maker Vitality
- Caraco Announces Merger Agreement with Sun Pharma
- BioCryst Awarded Additional $55.0 Million by the U.S. Department of Health & Human Services..
- Quintiles inks drug manufacturing deal with Samsung
- PS9000 ACCREDITATION FOR CHESTER MEDICAL SOLUTIONS
- Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
- ELC GROUP appoints former TOPRA President
- TRAVTEC SYSTEMS EASE CODING COMPLIANCE AT ASTRAZENECA
- Clostridium Difficile Drug Wins FDA Approval
- Optimer Pharma antibacterial drug gets FDA approval
- SCHOTT Inaugurates New Pharmaceutical Packaging Production in Russia
- New CPD Rules and Framework come into effect on 2 July 2011
- APP Pharmaceuticals Announces Approval of Levothyroxine Sodium for Injection
- Antitrust: Commission welcomes new decrease in problematic pharma patent settlements in the EU
- Holder Lied: DOJ News Release Shows Obama Admin Approved ATF Mexico Weapons Smuggling
- Top execs will meet in Shanghai China to discuss healthcare supply chain issues
- Lonza signs manufacturing deal with Immune Pharmaceuticals for Bertilimumab
- Prescription-drug prices to plunge as patents expire
- Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
- Govt mulls restrictions on MNC buyouts of local pharma cos
- Beth Ann McKenna Stands Out in the Scientific Research Field
- POZEN Welcomes Dr. Seth A. Rudnick to the Board of Directors
- Unilife CEO to Purchase an Additional U.S. $500,000 in Company Shares by September 30, 2011
- Skila Sponsoring at Pharma Marketing Excellence Europe 2011
- DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insuffi
- US Patent Office Rejects All 191 Claims in Key MonoSol Patent Asserted Against BioDelivery Sciences
- Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Me
- Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient
- Sterling-Hoffman completes OEM Sales Specialist search for pharmaceutical company
- Insight: Stem cell therapy poised to come in from the cold
- West’s Q2 sales and profits climb
- Functions of Paracrine PDGF Signaling
- West buys Plastef’s delivery business
- 'Social justice' in health care
- New Report gives Insight to the Advanced Digital Diagnostic Medical Imaging Equipment Market.
- Study finds spinosad more effective than permethrin in treating head lice
- Indian pharma market set to grow 12-15%
- India Pharmaceutical Market
- Teva Pharmaceutical reports 4th-quarter profit
- Vanda Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
- Bio-Rad Reports Record Fourth-Quarter and Full-Year 2009 Financial Results
- Drug Pipeline Analysis And Market Forecasts To 2016
- Hercules Technology Growth Capital Announces Additional New Commitments of Over $52 Million to New a
- Irish pharma sector must attract R&D to secure competitve edge
- Clinical research: an outsourcing opportunity
- Rexahn Pharmaceuticals To Present Data On Novel Anti-Cancer Small Molecule RX-8243 At The American..
- Cambodia Pharmaceuticals and Healthcare Report Q2 2010 - new market report released
- The Unfortunate NIH Report on Alzheimer’s Disease
- European shares edge up in subdued trading
- Growth of the Pharmaceutical Industry – Need for Research and Development
- AIDS, HIV patients getting help from pharmaceutical companies
- South Korea Pharmaceuticals and Healthcare Report Q3 2010
- Biotechnology Pharmaceutical Market in US 2009-2013
- Recycling is in vogue
- Insight Genetics Receives Contract From National Cancer Institute to Develop New Lung Cancer Test
- Affymetrix Announces Positive Operating Income and Net Income for Q4-2010
- Culture can carve leaders
- European Fieldbus Market - a new market research
- Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically..
- Cipla’s profits hit by core business slowdown and expenses on new plant
- Need for clinical researchers stressed
- Infogroup’s ORC International Announces Launch of New FDA & Regulatory Research Practice
- Taro contributed one third of Sun Pharma's consolidated net sales
- I arrived in healthcare communications having spent 12 years as a creative PR consultant within the
- Pharmaceutical Industry Veterans Establish BioEndpoint Consulting To Offer Strategic Insight And Exp
- Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 a
- Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer
- DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Great
- New Pharmaceuticals market report from Datamonitor
- Vertex, Merck face little payer pushback with newly marketed HCV drugs
- Hedge Funds Pay Top Dollar for Washington Intelligence
- Neuromodulation Devices: World Market Prospects 2011-2021
- US FDA approves Antares' oxybutynin gel for overactive bladder treatment
- Direction of Market Influences - Report Highlights Questcor Pharmaceuticals, Inc. and Perrigo Compan
- Spending Trends in the CMO and CSO Market
- Korea Partnered with Global Pharma Expert Group to Expand its Bio-Pharma Business in the US
- Potential new Alzheimer's drug discovered
- NDA submitted for Acurox
- Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R)
- SFDA approval filed for TPIAO label extension
- AstraZeneca's drug would be the new clinical gold standard by 2012
- NDA permission for Ceplene®
- British Health Agency recommends Pfizer's Sutent
- cGMP collaboration between PacificGMP and LigoCyte Pharmaceuticals
- Generic Imitrex(R) tablets approved and launched
- Orexo's AbstralTM receives approvals in France and Spain
- FDA approval of Lexapro(R) for adolescent depressive disorder
- Pharmaxis announces milestone in phase II trial for cystic fibrosis
- Arginine vasopressin receptor antagonist now available in new premixed formulation
- Xanodyne’s new drug application for treating heavy menstrual bleeding accepted
- Emerging Spine Company Honored with 2009 Medical Design Excellence Award(R)
- Chinese Colorectal Cancer Drug Market Will More Than Double by 2012
- GSK Announces New Orders for Flu Vaccine
- Vectibix for Colorectal Cancer Shows Remarkable Survival Rates
- Biotech Survival In A Bleak Economy: The Story Of Addex Pharmaceuticals
- MiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving Measures
- Fovea Pharmaceuticals to be Acquired by sanofi-aventis
- Court Orders Forfeiture of $4.5 Million Against Pharmacia in Pharmaceutical Pricing Fraud Case
- Allegan Sues FDA to Allow Scientifically Backed Off Label Promotion
- Frutarom Launches New Global Branding
- Swine Flu Doesn't Need to Save Novartis
- Interested Clinical Trials, Doctors And Conflicts
- Drugmakers Will Pay More for Health Bill
- Luna Strengthens its Position in Nanomedicine
- BioMarin Pharmaceutical receives marketing approval for amifampridine phosphate
- Once Obama's target, lobbyist Tauzin now his pet
- Vietnam Pharmaceuticals And Healthcare Report Q1 2010 - New Report Published
- Adventrx Pharmaceuticals (ANX) Submits Cancer Drug to NDA Amid Takeover Rumors
- EyeGate Raises $22.6M In Venture Funding
- Ministry reminds residents to be wary of buying medicines online
- BioCryst and moksha8 Announce Approval for the Importation & Use of peramivir in Mexico
- Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
- AMRI CFO to Present at Jefferies 2010 Global Healthcare Services Conference
- MP damns swine flu drugs lobby
- Rib-X Pharmaceuticals appoints new board member
- China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug
- GSK To Create New Pharmaceutical Jobs In UK
- BioMarin Pharmaceutical Inc. Beats Analyst Expectations
- Big Pharma starts believing in outside innovation
- Prescription-drug heists on the rise
- Nepentes plans 35 product launches in Poland in 2010
- NC business launches pharma tours to India
- Rexahn Pharma Presents a Landmark in Clinical Trial Data Interpretation
- Teva expected to lose patent infringement suit to Pfizer
- Pharma Leaders Call for More Industry Partnerships at Launch of New Drug Discovery and Development
- Grace Earns Medical Device Certification
- Swine flu: BMJ investigation confirms WHO experts in pay of ‘pharma’
- Aqua Pharmaceuticals bought by Illinois private equity firm
- EC approves change in posology of Circadin from 3 weeks to 3 months of treatment
- Johnson & Johnson And Crucell In Advanced Negotiations For An All Cash Public Offer Of 24.75 Per Ord
- Access Pharmaceuticals, Inc. Signs $30m MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
- Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
- Cardinal lands foothold in China
- French sue pharma firm over deadly diabetes drugFrench sue pharma firm over deadly diabetes drug
- Healthcare trade associations unveil LifeSciencesUK
- Generic-drug ‘solution’ for Africa not needed
- Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following..
- Takeda ARB blood pressure medication approved by FDA
- Dipexium Pharmaceuticals Updates Locilex™ Development Activities and Announces 2011 Milestones
- Parkinson's relief ruled too costly
- Lexicon Pharma's diabetes drug shows positive results
- Cardium To Acquire Substantially All Business Assets Of Transdel Pharma
- Japan ushers in big meds from AZ, GSK, Merck Read more: Japan ushers in big meds from AZ, GSK, Merc
- Generics of antibiotic Levaquin approved by FDA
- FDA approves pain killer Fentanyl in nasal spray form Continue reading on Examiner.com FDA approves
- Equity funds led by FMCG, Pharma provided luring returns in June
- Biogen, Perrigo Remain Healthiest Drug Cos. On IBD 50
- Tour de France 2011, stage nine: race details
- Surveys of pharma execs see more rocky times ahead Read more/business
- Transcept shares sink as insomnia drug hits FDA hurdle
- ANC to push for state drugs maker
- RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership
- Watson Pharmaceuticals Earnings Preview
- Pakistani companies lag behind their Indian, Chinese counterparts
- Fired Techie Created Virtual Chaos at Pharma Company
- AstraZeneca wins FDA approval for blockbuster hopeful Brilinta
- Edmontonians warned of toxic smoke from pharmaceutical blaze
- Dr. Richard Nichol Joins Skila’s Board of Directors
- DoP reworking on several rejected schemes to reintroduce them in 12th Plan
- Astellas's Blood-Thinning Drug Raises Bleeding In Mid-Stage Study
- Major shareholder plans Omega Pharma buyout
- Alexion Pharma's Soliris Astellas volunteers spruce up Waukegan PADS site to ‘keep hope alive’
- Professor earns American Association of Pharmaceutical Scientists' highest honor
- Suit accuses pharma companies of Medicaid price-data manipulation
- Are You Mentally Ill? If You Drink Too Much You Are, Says Big Pharma
- Orion Pharma submits IPO prospectus
- World-leading Biomedical Engineer, Dr Robert Langer, Receives Economist Innovation Award for Bioscie
- Vertex Pharma seeks US FDA nod for Kalydeco to treat cystic fibrosis
- Nutra Pharma's MS drug neurotoxins receives US patent
- Nutra Pharma CEO Interviewed by Wall Street Reporter
- Drugmakers see pressure points in emerging markets
- Next Generation Pharmaceuticals Manufacturing US Summit 2011 Fosters Innovation For Industry Leading
- Lupin challenges tuberculosis drug price fixed by National Pharmaceutical Pricing Authority
- Emkay downgrades GlaxoSmithKline Pharma to `Reduce`
- Supreme Court will hear sales-rep overtime dispute
- United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Exam
- Radient Pharmaceuticals Corporation Receives $500,000 in New Capital
- Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
- Syndax Pharma, Ventana Medical enter pact to develop companion diagnostic test for entinostat
- Jan Bakelants starting early in first season with RadioShack-Nissan
- 4 Chinese drug manufacturing units under scanner
- Inovio Pharmaceutical's Pennvax HIV vaccine featured on ABC News
- Amid pharma talks, Ember Therapeutics notches win for obesity program
- Johnson & Johnson to pay $158 million in overcharging lawsuit
- Auxilium Pharma (AUXL) Shares Given New $24.00 Price Target by Bank of America (BAC) Analysts
- Omega Pharma-Quick Step, Liquigas-Cannondale and Colnago-CSF Bardiani send experience and youth
- Pharma giant presses on with investment despite general scepticism
- Watson Pharmaceuticals Incorporated (WPI) Shares Upgraded by Bank of America (BAC) to “Buy”
- Pharma majors’ multiple sclerosis drugs safe from EU competition for several years
- News
- Pharma majors’ multiple sclerosis drugs safe from EU competition for several years
- Watson Pharmaceuticals Incorporated (WPI) Shares Upgraded by Bank of America (BAC) to “Buy”
- Pharma giant presses on with investment despite general scepticism
- Omega Pharma-Quick Step, Liquigas-Cannondale and Colnago-CSF Bardiani send experience and youth
- Auxilium Pharma (AUXL) Shares Given New $24.00 Price Target by Bank of America (BAC) Analysts
- Johnson & Johnson to pay $158 million in overcharging lawsuit
- Amid pharma talks, Ember Therapeutics notches win for obesity program
- Inovio Pharmaceutical's Pennvax HIV vaccine featured on ABC News
- 4 Chinese drug manufacturing units under scanner
- Jan Bakelants starting early in first season with RadioShack-Nissan
- Syndax Pharma, Ventana Medical enter pact to develop companion diagnostic test for entinostat
- Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
- Radient Pharmaceuticals Corporation Receives $500,000 in New Capital
- United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Exam
- Supreme Court will hear sales-rep overtime dispute
- Emkay downgrades GlaxoSmithKline Pharma to `Reduce`
- Lupin challenges tuberculosis drug price fixed by National Pharmaceutical Pricing Authority
- Next Generation Pharmaceuticals Manufacturing US Summit 2011 Fosters Innovation For Industry Leading
- Drugmakers see pressure points in emerging markets
- Nutra Pharma CEO Interviewed by Wall Street Reporter
- Nutra Pharma's MS drug neurotoxins receives US patent
- Vertex Pharma seeks US FDA nod for Kalydeco to treat cystic fibrosis
- World-leading Biomedical Engineer, Dr Robert Langer, Receives Economist Innovation Award for Bioscie
- Orion Pharma submits IPO prospectus
- Are You Mentally Ill? If You Drink Too Much You Are, Says Big Pharma
- Suit accuses pharma companies of Medicaid price-data manipulation
- Professor earns American Association of Pharmaceutical Scientists' highest honor
- Alexion Pharma's Soliris Astellas volunteers spruce up Waukegan PADS site to ‘keep hope alive’
- Major shareholder plans Omega Pharma buyout
- Astellas's Blood-Thinning Drug Raises Bleeding In Mid-Stage Study
- DoP reworking on several rejected schemes to reintroduce them in 12th Plan
- Dr. Richard Nichol Joins Skila’s Board of Directors
- Edmontonians warned of toxic smoke from pharmaceutical blaze
- AstraZeneca wins FDA approval for blockbuster hopeful Brilinta
- Fired Techie Created Virtual Chaos at Pharma Company
- Pakistani companies lag behind their Indian, Chinese counterparts
- Watson Pharmaceuticals Earnings Preview
- RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership
- ANC to push for state drugs maker
- Transcept shares sink as insomnia drug hits FDA hurdle
- Surveys of pharma execs see more rocky times ahead Read more/business
- Tour de France 2011, stage nine: race details
- Biogen, Perrigo Remain Healthiest Drug Cos. On IBD 50
- Equity funds led by FMCG, Pharma provided luring returns in June
- FDA approves pain killer Fentanyl in nasal spray form Continue reading on Examiner.com FDA approves
- Generics of antibiotic Levaquin approved by FDA
- Japan ushers in big meds from AZ, GSK, Merck Read more: Japan ushers in big meds from AZ, GSK, Merc
- Cardium To Acquire Substantially All Business Assets Of Transdel Pharma
- Lexicon Pharma's diabetes drug shows positive results
- Parkinson's relief ruled too costly
- Dipexium Pharmaceuticals Updates Locilex™ Development Activities and Announces 2011 Milestones
- Takeda ARB blood pressure medication approved by FDA
- Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following..
- Generic-drug ‘solution’ for Africa not needed
- Healthcare trade associations unveil LifeSciencesUK
- French sue pharma firm over deadly diabetes drugFrench sue pharma firm over deadly diabetes drug
- Cardinal lands foothold in China
- Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
- Access Pharmaceuticals, Inc. Signs $30m MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
- Johnson & Johnson And Crucell In Advanced Negotiations For An All Cash Public Offer Of 24.75 Per Ord
- EC approves change in posology of Circadin from 3 weeks to 3 months of treatment
- Aqua Pharmaceuticals bought by Illinois private equity firm
- Swine flu: BMJ investigation confirms WHO experts in pay of ‘pharma’
- Grace Earns Medical Device Certification
- Pharma Leaders Call for More Industry Partnerships at Launch of New Drug Discovery and Development
- Teva expected to lose patent infringement suit to Pfizer
- Rexahn Pharma Presents a Landmark in Clinical Trial Data Interpretation
- NC business launches pharma tours to India
- Nepentes plans 35 product launches in Poland in 2010
- Prescription-drug heists on the rise
- Big Pharma starts believing in outside innovation
- BioMarin Pharmaceutical Inc. Beats Analyst Expectations
- GSK To Create New Pharmaceutical Jobs In UK
- China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug
- Rib-X Pharmaceuticals appoints new board member
- MP damns swine flu drugs lobby
- AMRI CFO to Present at Jefferies 2010 Global Healthcare Services Conference
- Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
- Ministry reminds residents to be wary of buying medicines online
- BioCryst and moksha8 Announce Approval for the Importation & Use of peramivir in Mexico
- EyeGate Raises $22.6M In Venture Funding
- Adventrx Pharmaceuticals (ANX) Submits Cancer Drug to NDA Amid Takeover Rumors
- Vietnam Pharmaceuticals And Healthcare Report Q1 2010 - New Report Published
- Once Obama's target, lobbyist Tauzin now his pet
- BioMarin Pharmaceutical receives marketing approval for amifampridine phosphate
- Luna Strengthens its Position in Nanomedicine
- Drugmakers Will Pay More for Health Bill
- Interested Clinical Trials, Doctors And Conflicts
- Swine Flu Doesn't Need to Save Novartis
- Frutarom Launches New Global Branding
- Allegan Sues FDA to Allow Scientifically Backed Off Label Promotion
- Court Orders Forfeiture of $4.5 Million Against Pharmacia in Pharmaceutical Pricing Fraud Case
- Fovea Pharmaceuticals to be Acquired by sanofi-aventis
- MiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving Measures
- Biotech Survival In A Bleak Economy: The Story Of Addex Pharmaceuticals
- Vectibix for Colorectal Cancer Shows Remarkable Survival Rates
- GSK Announces New Orders for Flu Vaccine
- Chinese Colorectal Cancer Drug Market Will More Than Double by 2012
- Emerging Spine Company Honored with 2009 Medical Design Excellence Award(R)
- Xanodyne’s new drug application for treating heavy menstrual bleeding accepted
- Arginine vasopressin receptor antagonist now available in new premixed formulation
- Pharmaxis announces milestone in phase II trial for cystic fibrosis
- FDA approval of Lexapro(R) for adolescent depressive disorder
- Orexo's AbstralTM receives approvals in France and Spain
- Generic Imitrex(R) tablets approved and launched
- cGMP collaboration between PacificGMP and LigoCyte Pharmaceuticals
- British Health Agency recommends Pfizer's Sutent
- NDA permission for Ceplene®
- AstraZeneca's drug would be the new clinical gold standard by 2012
- SFDA approval filed for TPIAO label extension
- Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R)
- NDA submitted for Acurox
- Potential new Alzheimer's drug discovered
- Korea Partnered with Global Pharma Expert Group to Expand its Bio-Pharma Business in the US
- Press Releases
- Sterling-Hoffman completes OEM Sales Specialist search for pharmaceutical company
- Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient
- Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Me
- US Patent Office Rejects All 191 Claims in Key MonoSol Patent Asserted Against BioDelivery Sciences
- DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insuffi
- Skila Sponsoring at Pharma Marketing Excellence Europe 2011
- Unilife CEO to Purchase an Additional U.S. $500,000 in Company Shares by September 30, 2011
- POZEN Welcomes Dr. Seth A. Rudnick to the Board of Directors
- Beth Ann McKenna Stands Out in the Scientific Research Field
- Govt mulls restrictions on MNC buyouts of local pharma cos
- Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
- Prescription-drug prices to plunge as patents expire
- Lonza signs manufacturing deal with Immune Pharmaceuticals for Bertilimumab
- Top execs will meet in Shanghai China to discuss healthcare supply chain issues
- Holder Lied: DOJ News Release Shows Obama Admin Approved ATF Mexico Weapons Smuggling
- Antitrust: Commission welcomes new decrease in problematic pharma patent settlements in the EU
- APP Pharmaceuticals Announces Approval of Levothyroxine Sodium for Injection
- New CPD Rules and Framework come into effect on 2 July 2011
- SCHOTT Inaugurates New Pharmaceutical Packaging Production in Russia
- Optimer Pharma antibacterial drug gets FDA approval
- Clostridium Difficile Drug Wins FDA Approval
- TRAVTEC SYSTEMS EASE CODING COMPLIANCE AT ASTRAZENECA
- ELC GROUP appoints former TOPRA President
- Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
- PS9000 ACCREDITATION FOR CHESTER MEDICAL SOLUTIONS
- Quintiles inks drug manufacturing deal with Samsung
- BioCryst Awarded Additional $55.0 Million by the U.S. Department of Health & Human Services..
- Caraco Announces Merger Agreement with Sun Pharma
- Dr Soon-Shiong acquires GlowCaps-maker Vitality
- BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
- Cyplasin Biomedical Ltd Announces Corporate 2010 Update
- Cadila Pharmaceuticals secures Wellcome Trust Award
- BJS Biotechnologies launches UF1 at Biotechnica
- AmerisourceBergen Authorizes a New $500 Million Share Repurchase Program
- Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl
- FDA Panel Rejects Arena's Weight-Loss Drug
- Novo launches insulin dosing app
- Par Pharmaceutical Begins Shipment of Generic Zegerid®
- BASF Fine Chemicals Switzerland SA and BASF Orgamol Pharma Solutions SA merger announced
- Johnson & Johnson Pharmaceutical Research & Development Reports Phase 2b Clinical Trial Results
- Valeant Acquires Aton Pharma
- Mission Pharmacal Launches New Prescription Prenatal Vitamin, CitraNatal® Harmony
- Lorus Therapeutics Announces Share Consolidation
- FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
- CPEX Pharmaceuticals Appoints Robert Forrester To Board Of Directors
- Inspire shares rise on dry-eye product approval
- Pharmaceutical Companies How to Comply with New FDA Expectations for Quality Systems
- Impax Laboratories Schedules Conference Call for First Quarter 2010 Financial Results Read more: ht
- dinlivskraft.se Announces The Launch Of Its New D-Vitamin Supplements
- King Pharmaceuticals Announces US Department of Justice Settlement
- European Medicines Agency Grants to ADIENNE Pharma and Biotech the exclusive Marketing Authorization
- Vicor Technologies, Inc. (OTCBB: VCRT) A New Vital Sign
- Global Anti Counterfeit Packaging Technologies Market for Food and Pharmaceuticals
- Simcere Pharmaceutical Group Announces Addition to Senior Management Team
- U.S. Food and Drug Administration Approves Cayston(R) for the Improvement of Respiratory Sym
- Clarient to Release 2009 Fourth Quarter and Year-End Financial Results on Wednesday, March 10th
- Approval in Japan of New Formulation of Mitsubishi Tanabe Pharma's Edaravone Will Further Bolster it
- Vertex Pharmaceuticals Announces Redemption Date for 4.75% Convertible Senior Subordinated Notes due
- Ceplene® Included in Swedish AML Medical Guidelines Announced by EpiCept
- Product Placement Initiated Means Roll Out Beginning
- Teva Announces Tentative Approval of Generic Femara® Tablets
- FDA has approved the marketing of Ampyra™
- Novo Nordisk A/S: Regulatory Approval
- Vertex Reviews 2010 Business Priorities to Support Goal of Becoming Fully-Capable Biopharmaceutical
- Mindlance Life Sciences Acquires Pharmaceutical Clinical Associates
- T-Ray Science, Inc. Announces Changes in Management
- Four Leading Pharmaceutical Companies Select Cegedim Dendrite’s Customer Master Data Management Solu
- BPA: It's in Your Urine. But Is It Safe?
- Caleco Pharma Corp. (CAEH.OB) Leads The Best Stock Picks List
- NPA group wins PPMA elections
- Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
- MicroBioLogics Releases New Product For Growth Promotion Testing Of Microbiological Culture Media In
- Financing Outlook for the US Biotechnology Industry
- Luna Innovations to Provide Corporate Update on January 11, 2010
- Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
- Biodel seeks US FDA approval for mealtime insulin VIAject to treat diabetes
- Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experi
- FDA approves pralatrexate for peripheral T-cell lymphoma
- Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Gl
- Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
- BET Surface Area – A Useful Tool for Determining the Source of Batch-to-Batch Variation in Processab
- Durham biotech Chimerix raises $16.1 million
- New Peptide shown even more effective compared to hydroquinone
- New Sani-Tech(R) Ultra delivers improved performance
- KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for GERD Treatment
- Immunotech Completes Merger Acquisition
- Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Resea
- Non-safety-related voluntary market patches announced
- Nimotuzumab In Non-Small-Cell Lung Cancer
- Hospitalizations and Emergency Room Visits
- Heat-Stable Version of HIV Protease Inhibitor
- Treat Moderate to Severe Acne Scars
- Intas Biopharma to market PEMETREXED in India
- FDA approval for extended-release tramadol capsules
- Enzon Announces IND Acceptance for Its Survivin Antagonist
- USA to Establish Helsinn Therapeutics (US) Inc. - Announced by Helsinn
- Pfizer to Acquire Wyeth, Creating the World s Premier Biopharmaceutical Company
- ThromboGenics Begins Phase III Program With Microplasmin
- Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
- Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuti
- Roger Tung, CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE
- Alexion Receives CHMP Positive Opinion for Soliris(R) (eculizumab) in Patients with Atypical Hemolyt
- Research Insight
- Spending Trends in the CMO and CSO Market
- Direction of Market Influences - Report Highlights Questcor Pharmaceuticals, Inc. and Perrigo Compan
- US FDA approves Antares' oxybutynin gel for overactive bladder treatment
- Neuromodulation Devices: World Market Prospects 2011-2021
- Hedge Funds Pay Top Dollar for Washington Intelligence
- Vertex, Merck face little payer pushback with newly marketed HCV drugs
- New Pharmaceuticals market report from Datamonitor
- DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Great
- Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer
- Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 a
- Pharmaceutical Industry Veterans Establish BioEndpoint Consulting To Offer Strategic Insight And Exp
- I arrived in healthcare communications having spent 12 years as a creative PR consultant within the
- Taro contributed one third of Sun Pharma's consolidated net sales
- Infogroup’s ORC International Announces Launch of New FDA & Regulatory Research Practice
- Need for clinical researchers stressed
- Cipla’s profits hit by core business slowdown and expenses on new plant
- Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically..
- European Fieldbus Market - a new market research
- Culture can carve leaders
- Affymetrix Announces Positive Operating Income and Net Income for Q4-2010
- Insight Genetics Receives Contract From National Cancer Institute to Develop New Lung Cancer Test
- Recycling is in vogue
- Biotechnology Pharmaceutical Market in US 2009-2013
- South Korea Pharmaceuticals and Healthcare Report Q3 2010
- AIDS, HIV patients getting help from pharmaceutical companies
- Growth of the Pharmaceutical Industry – Need for Research and Development
- European shares edge up in subdued trading
- The Unfortunate NIH Report on Alzheimer’s Disease
- Cambodia Pharmaceuticals and Healthcare Report Q2 2010 - new market report released
- Rexahn Pharmaceuticals To Present Data On Novel Anti-Cancer Small Molecule RX-8243 At The American..
- Clinical research: an outsourcing opportunity
- Irish pharma sector must attract R&D to secure competitve edge
- Hercules Technology Growth Capital Announces Additional New Commitments of Over $52 Million to New a
- Drug Pipeline Analysis And Market Forecasts To 2016
- Bio-Rad Reports Record Fourth-Quarter and Full-Year 2009 Financial Results
- Vanda Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
- Teva Pharmaceutical reports 4th-quarter profit
- India Pharmaceutical Market
- Indian pharma market set to grow 12-15%
- Study finds spinosad more effective than permethrin in treating head lice
- New Report gives Insight to the Advanced Digital Diagnostic Medical Imaging Equipment Market.
- 'Social justice' in health care
- West buys Plastef’s delivery business
- Functions of Paracrine PDGF Signaling
- West’s Q2 sales and profits climb
- Insight: Stem cell therapy poised to come in from the cold
- Articles
- Pain-free PCR: BJS Biotechnologies creates UF1
- Coming attractions in life sciences
- pharmaceuticals are Weapons of Mass Prescription
- Dangerous prescription drugs might really be.
- Health Care Reform will not fly!
- Improving Performance - Pharmaceutical Manufacturing
- Understanding the Psyche of Japanese Pharmaceutical Consumers
- Industry Updates
- A bright spark of innovation could be our lifesaver
- Golden age fades for drug companies
- Healthcare IT and pharma M&A strongly supported by investment firms in 2011
- Proposed Clinical Drug Act Raises Eyebrows
- MULTIVAC further expands its activities for the medical and pharmaceutical industries
- Pharmaceutical Industry Confronting Big Challenges, Opportunities in 2012
- Teva Pharma appoints Jeremy Levin as CEO of Bristol-Myers
- Is the American Psychiatric Association in Bed with Big Pharma?
- Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes
- Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Th
- Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharm
- FDA Aims to Bridge Communication Gap with Drug Industry During Reviews Through PDUFA V
- Watchdog wants answers on Pfizer payments deal
- Leaked US Proposal for a TPP Pharmaceutical Chapter
- Latham Lands Roles on Pair of Health Care Industry Deals
- UCSF Symposium Showcases New Technologies to Accelerate Drug Development
- Ind Ministry gives dissent note to committee on FDI in pharma
- Drug Shortages Threaten Cancer Research
- Drugmakers ask government to allow FDI in pharma sector
- Coalition Pursues Tax Breaks for Biotechs that Repatriate Revenue or Invest in R&D
- O.C. generic drug maker sold for $410 million
- Delegation of powers to CDSCO zonal offices is to help pharma exporters
- Granules India to augment APIs production, expand market share of best sellers
- Drug Registration Board meting held
- FDA, Generics Industry Compromise For User-Fee Agreement
- Drug firms consider delaying PBS listings
- International Study of Genetic Alzheimer's Disease Gives Clues to Presymptomatic Detection and Progr
- Global Pharmaceutical Supplier Industry Outlook Survey
- Drug discounts for debt cuts may lose 260,000 jobs, group says Read more.
- Health system 'will suffer' if Pharmac changes go ahead
- Health system 'will suffer' if Pharmac changes go ahead
- Clutch of drug companies found in breach of code of practice
- Pharma industry, trade back Task Force for launching track & trace system
- costly war on cancer
- Disincentives to Adopting New Drug Delivery Systems
- Pharma companies settle Kentucky's AWP suits
- UW a force in pain drug growth
- Travtec Launches New Coder for Pharma Packaging
- Aurobindo Pharma
- Medivir reports HCV drug study positive results
- RXi Pharmaceuticals Initiates Development Program for Dermal Anti-Scarring Product Candidate
- Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
- Pharmaceutical stocks have been among the weakest performers in Europe and they face even more turbu
- Perrigo Launches Two New Generics
- Market Access Korea - Breaking into the Developed Worlds Fastest Growing Pharmaceutical Market
- Infoway adds diagnostic imaging, drug information systems to Certification Services
- WCO Signs Declaration, Vows To Crack Down On Counterfeit Drug Industry
- New Core Imaging Lab, Imaging Endpoints, Launches in Arizona
- Generic Products And Their Benefits To Society
- Julphar launches new packs for its chain of pain killing medicines
- Novo Nordisk To Launch Victoza In Japan In June
- Egypt Pharmaceuticals And Healthcare Report Q3 2010
- Pfizer closures another blow to Puerto Rico economy
- Michigan Compounding Pharmacy Launches New Drug Take-Back Program for Consumer Drug Disposal
- Pfizer’s investment plans, new launches to drive growth in 2010
- IMS Health Reports Growth in U.S. Sales of Ethical Pharmaceuticals
- Royal Pharmaceutical Society launches new science advisory panel
- Industry Calls for Qualified Transport to Secure Supply Chain
- Best Pharmaceutical Stock Alert
- BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential
- Laboratory Instruments Manufacturer
- Striped Nanoparticles Improve Drug Delivery System
- Planning a Double-Door Autoclave for Clean
- Air-Cooled Peltier Accessories for Accurate Temperature Control
- Device to Control Gene Activity Produced
- Automating Life Sciences Compliance
- Painless Needle-free Injections - Micro-Jets
- Pharma 2020: The vision - which path will you take?
- Pharma 2020: Virtual R&D
- Superdisintegrant Performance - A Case Study with Croscarmellose Sodium
- White Papers
- Techno Trends
- Disincentives to Adopting New Drug Delivery Systems
- Travtec Launches New Coder for Pharma Packaging
- RXi Pharmaceuticals Initiates Development Program for Dermal Anti-Scarring Product Candidate
- Perrigo Launches Two New Generics
- Infoway adds diagnostic imaging, drug information systems to Certification Services
- New Core Imaging Lab, Imaging Endpoints, Launches in Arizona
- Novo Nordisk To Launch Victoza In Japan In June
- Michigan Compounding Pharmacy Launches New Drug Take-Back Program for Consumer Drug Disposal
- Royal Pharmaceutical Society launches new science advisory panel
- Striped Nanoparticles Improve Drug Delivery System
- Air-Cooled Peltier Accessories for Accurate Temperature Control
- Device to Control Gene Activity Produced
- Painless Needle-free Injections - Micro-Jets
- Industry Reports
- A bright spark of innovation could be our lifesaver
- Golden age fades for drug companies
- Healthcare IT and pharma M&A strongly supported by investment firms in 2011
- Proposed Clinical Drug Act Raises Eyebrows
- MULTIVAC further expands its activities for the medical and pharmaceutical industries
- Pharmaceutical Industry Confronting Big Challenges, Opportunities in 2012
- Teva Pharma appoints Jeremy Levin as CEO of Bristol-Myers
- Is the American Psychiatric Association in Bed with Big Pharma?
- Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes
- Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Th
- Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharm
- FDA Aims to Bridge Communication Gap with Drug Industry During Reviews Through PDUFA V
- Watchdog wants answers on Pfizer payments deal
- Leaked US Proposal for a TPP Pharmaceutical Chapter
- Latham Lands Roles on Pair of Health Care Industry Deals
- UCSF Symposium Showcases New Technologies to Accelerate Drug Development
- Ind Ministry gives dissent note to committee on FDI in pharma
- Drug Shortages Threaten Cancer Research
- Drugmakers ask government to allow FDI in pharma sector
- Coalition Pursues Tax Breaks for Biotechs that Repatriate Revenue or Invest in R&D
- O.C. generic drug maker sold for $410 million
- Delegation of powers to CDSCO zonal offices is to help pharma exporters
- Granules India to augment APIs production, expand market share of best sellers
- Drug Registration Board meting held
- FDA, Generics Industry Compromise For User-Fee Agreement
- Drug firms consider delaying PBS listings
- International Study of Genetic Alzheimer's Disease Gives Clues to Presymptomatic Detection and Progr
- Global Pharmaceutical Supplier Industry Outlook Survey
- Drug discounts for debt cuts may lose 260,000 jobs, group says Read more.
- Health system 'will suffer' if Pharmac changes go ahead
- Health system 'will suffer' if Pharmac changes go ahead
- Clutch of drug companies found in breach of code of practice
- Pharma industry, trade back Task Force for launching track & trace system
- costly war on cancer
- Pharma companies settle Kentucky's AWP suits
- UW a force in pain drug growth
- Aurobindo Pharma
- Medivir reports HCV drug study positive results
- Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
- Pharmaceutical stocks have been among the weakest performers in Europe and they face even more turbu
- Market Access Korea - Breaking into the Developed Worlds Fastest Growing Pharmaceutical Market
- WCO Signs Declaration, Vows To Crack Down On Counterfeit Drug Industry
- Generic Products And Their Benefits To Society
- Julphar launches new packs for its chain of pain killing medicines
- Egypt Pharmaceuticals And Healthcare Report Q3 2010
- Pfizer closures another blow to Puerto Rico economy
- Pfizer’s investment plans, new launches to drive growth in 2010
- IMS Health Reports Growth in U.S. Sales of Ethical Pharmaceuticals
- Best Pharmaceutical Stock Alert
- BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential
- Laboratory Instruments Manufacturer
- Pharma 2020: The vision - which path will you take?
- Pharma 2020: Virtual R&D
- Superdisintegrant Performance - A Case Study with Croscarmellose Sodium
- Advertise
Top Menu
Pharmatechglobal.net is a product of JMC IT MAHAL PVT.LTD. Reg # 063984. TIN # AACCJ2429F
© 2007 - 2010 JMC IT MAHAL PVT.LTD. All Right Reserved. for Inquiry e-mail : info@itmahal.com
 |